Financial Express (Holdings) Limited (“we”, “our”, “us” and derivatives) are committed to protecting and respecting your privacy. This Privacy Policy, together with our Terms of Use, sets out the basis on which any personal data that we collect from you, or that you provide to us, will be processed by us relating to your use of any of the below websites (“sites”).


For the purposes of the Data Protection Act 1998, the data controller is Trustnet Limited of 2nd Floor, Golden House, 30 Great Pulteney Street, London, W1F 9NN. Our nominated representative for the purpose of this Act is Kirsty Witter.


We collect information about you when you register with us or use any of our websites / services. Part of the registration process may include entering personal details & details of your investments.

We may collect information about your computer, including where available your operating system, browser version, domain name and IP address and details of the website that you came from, in order to improve this site.

You confirm that all information you supply is accurate.


In order to provide personalised services to and analyse site traffic, we may use a cookie file which is stored on your browser or the hard drive of your computer. Some of the cookies we use are essential for the sites to operate and may be used to deliver you different content, depending on the type of investor you are.

You can block cookies by activating the setting on your browser which allows you to refuse the setting of all or some cookies. However, if you use your browser settings to block all cookies (including essential cookies) you may not be able to access all or part of our sites. Unless you have adjusted your browser setting so that it will refuse cookies, our system will issue cookies as soon as you visit our sites.


We store and use information you provide as follows:

  • to present content effectively;
  • to provide you with information, products or services that you request from us or which may interest you, tailored to your specific interests, where you have consented to be contacted for such purposes;
  • to carry out our obligations arising from any contracts between you and us;
  • to enable you to participate in interactive features of our service, when you choose to do so;
  • to notify you about changes to our service;
  • to improve our content by tracking group information that describes the habits, usage, patterns and demographics of our customers.

We may also send you emails to provide information and keep you up to date with developments on our sites. It is our policy to have instructions on how to unsubscribe so that you will not receive any future e-mails. You can change your e-mail address at any time.

In order to provide support on the usage of our tools, our support team need access to all information provided in relation to the tool.

We will not disclose your name, email address or postal address or any data that could identify you to any third party without first receiving your permission.

However, you agree that we may disclose to any regulatory authority to which we are subject and to any investment exchange on which we may deal or to its related clearing house (or to investigators, inspectors or agents appointed by them), or to any person empowered to require such information by or under any legal enactment, any information they may request or require relating to you, or if relevant, any of your clients.

You agree that we may pass on information obtained under Money Laundering legislation as we consider necessary to comply with reporting requirements under such legislation.


We want to ensure that the personal information we hold about you is accurate and up to date. You may ask us to correct or remove information that is inaccurate.

You have the right under data protection legislation to access information held about you. If you wish to receive a copy of any personal information we hold, please write to us at 3rd Floor, Hollywood House, Church Street East, Woking, GU21 6HJ. Any access request may be subject to a fee of £10 to meet our costs in providing you with details of the information we hold about you.


The data that we collect from you may be transferred to, and stored at, a destination outside the European Economic Area (“EEA”). It may be processed by staff operating outside the EEA who work for us or for one of our suppliers. Such staff may be engaged in, amongst other things, the provision of support services. By submitting your personal data, you agree to this transfer, storing and processing. We will take all steps reasonably necessary, including the use of encryption, to ensure that your data is treated securely and in accordance with this privacy policy.

Unfortunately, the transmission of information via the internet is not completely secure. Although we will do our best to protect your personal data, we cannot guarantee the security of your data transmitted to our sites; any transmission is at your own risk. You will not hold us responsible for any breach of security unless we have been negligent or in wilful default.


Any changes we make to our privacy policy in the future will be posted on this page and, where appropriate, notified to you by e-mail.


Our sites contain links to other websites. If you follow a link to any of these websites, please note that these websites have their own privacy policies and that we do not accept any responsibility or liability for these policies. Please check these policies before you submit any personal data to these websites.


If you want more information or have any questions or comments relating to our privacy policy please email [email protected] in the first instance.

 Information  X 
Enter a valid email address

Cherwell Capital PLC (CHEP)

  Print      Mail a friend

Friday 07 March, 2008

Cherwell Capital PLC

Interim Results

                                CHERWELL CAPITAL PLC


                  For the six months ending 30th September 2007.

I have pleasure in presenting to our shareholders Cherwell Capital Plc's
unaudited interim figures. These cover the six month period to 30th September
2007 and include a brief review of the progress of our individual investments.

Cherwell's net asset value at 30th September 2007 amounted to £380,611 (2.91p/
share) compared to £387,596 (2.97p/share) for the period ending 31st March 2007
The carrying value of our investments remains unchanged at the book value of £


BioAnaLab has continued to show strong growth in revenue and profitability from
the provision of analytical services to the pharmaceutical industry.

Scancell, the biopharmaceutical company developing unique approaches to the
treatment of cancer using therapeutic monoclonal antibody technologies - these
have the ability to directly kill cells in clinically relevant tumours - has
just announced its first clinical candidate drug for the treatment of melanomas
(skin cancers).

MindWeavers has completed a pre-IPO funding prior to a possible application
later in the year for a listing on PLUSMarkets. The company has experienced
growth in sales in both the "MindFit-Brain Power Fitness" software, which has
won a business and award, and in the "Phonomena" language development software.

Enkephala is continuing with its ongoing Research & Development into possible
markers for Alzheimers disease.

OxLoc has raised further funding for development of its tracking/monitoring

Professor Bruce Savage,
Chairman - Cherwell Capital plc
20th February, 2008

Interim unaudited figures for 6 months to 30.9.07


                      6 Months ended           12 Months ended           6 Months ended      
                        30/09/2007               31/03/2007                30/09/2006        
                  Revenue Capital   Total  Revenue Capital    Total  Revenue Capital    Total
                        £       £       £        £       £        £        £       £        £
Gains/(Losses) on                                                                           0
Income                                                                     0                0
Other expenses    (6,985)         (6,985) (20,786)         (20,786) (12,877)         (12,877)
Return on         (6,985)       0 (6,985) (20,786)       0 (20,786) (12,877)       0 (12,877)
before tax                                                                                   
Tax on ordinary         -       -       -        -       -        -        -       -        -
Return            (6,985)       0 (6,985) (20,786)       0 (20,786) (12,877)       0 (12,877)
attributable to                                                                              
shareholders and                                                                             
transfers to                                                                                 
Return per share  (0.05)p         (0.05)p  (0.16)p          (0.16)p  (0.10)p          (0.10)p
General Notes to the Accounts                                                                                 

1) The financial information for the 6 month period ended 30 September 2007 is
unaudited and does not constitute statutory accounts within the meaning of the
Companies Act 1985. The financial information for the year ended 31 March 2007
has been extracted from the Company's statutory accounts for that period which
contained an unqualified report and which have been filed with the Registrar of
Companies. The accounting policies remain unchanged from those set out in the
Company's statutory accounts for the year ended 31 March 2007

2) In accordance with PLUS Market listing requirements Rule 9.12, the directors
take full responsibility for the figures and statements made in these accounts.

Interim Unaudited Figures for 6 Months to 30.9.07


                                            As at           As at         As at
                                         30.09.07        31.03.07      30.09.06
                                                £               £             £
Fixed Assets                                                                   
Tangible assets                                 2               2           395
Fixed Assets - Investments                                                                    
Investments                               321,060         321,060       316,062
                                          321,062         321,062       316,457
Current Assets                                                                 
Debtors                                    90,273          94,020       100,300
Cash at bank and in hand                        -               -             -
                                           90,273          94,020       100,300
Creditors:amounts falling due            (30,724)        (27,486)      (21,253)
within one year                                                                
Net current assets                         59,549          66,534        79,047
Net assets                                380,611         387,596       395,504
Capital and reserves                                                           
Called up share capital                   326,633         326,633       326,633
Share premium account                     107,970         107,970       107,970
Other reserve                              10,250          10,250        10,250
Capital reserve -                         (1,423)         (1,423)       (1,423)
Capital reserve -                        (16,904)        (16,904)      (16,904)
Revenue reserve                          (45,915)        (38,930)      (31,022)
                                          380,611         387,596       395,504

Note to the balance sheet as at 30.09.07                                                           

The listed investments have been revalued at the half year, if appropriate.
Unlisted equity investments are stated at cost or subsequent issue price in
accordance with the British Venture Capital Association guidelines for the
valuation of unlisted companies.


a d v e r t i s e m e n t